Ayala Pharmaceuticals, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Kost Forer Gabbay & Kasierer, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 USD | -2.27% | -2.27% | -67.77% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-67.77% | 93.79L | |
+64.92% | 6.26TCr | |
-1.85% | 4.12TCr | |
+44.76% | 4.03TCr | |
-8.93% | 2.79TCr | |
+13.05% | 2.62TCr | |
-21.96% | 1.91TCr | |
+4.21% | 1.31TCr | |
+25.74% | 1.23TCr | |
+27.42% | 1.21TCr |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Ayala Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt